GlassScriptPhysician profile
Laura Moffat
NPI 1184645160
$3,214.70
in general payments reported to CMS, 2019-2025
35 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $126 · 2021: $796 · 2022: $1,005 · 2023: $450 · 2024: $342 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $67.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.21 |
| Education | $67.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.17 | 2020-2023 | |
| Aspira Women'S Health INC | $418.10 | 2021-2024 | Ova1 |
| Exeltis, USA INC. | $213.63 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $195.15 | 2020-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $188.11 | 2020-2022 | |
| Intuitive Surgical, INC. | $161.12 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $145.10 | 2023-2024 | Myfembree |
| Medtronic, INC. | $131.56 | 2022-2024 | V-Loc 180 |
| Channel Medsystems, INC. | $126.86 | 2021 | |
| Mayne Pharma Commercial LLC | $111.62 | 2021-2025 | |
| Sage Therapeutics, LLC | $104.49 | 2024-2025 | Zurzuvae |
| Organon LLC | $77.67 | 2022-2024 | |
| Boston Scientific Corporation | $71.73 | 2025 | General - Female Sui |
| Urovant Sciences INC | $63.99 | 2022 | |
| Myovant Sciences INC. | $58.12 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $56.22 | 2023-2024 | Accrufer |
| Amgen INC. | $46.55 | 2019-2022 | |
| Hologic Sales and Service, LLC | $41.39 | 2019-2020 | |
| Ethicon US, LLC | $35.60 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.36 | 2019 | |
| Agile Therapeutics, INC. | $31.96 | 2021-2022 | |
| Millicent US INC | $23.86 | 2025 | Intrarosa |
| Merck Sharp & Dohme LLC | $22.42 | 2019 | |
| Avion Pharmaceuticals | $19.64 | 2022 | |
| Supernus Pharmaceuticals, INC. | $19.24 | 2025 | Qelbree |
| Coopersurgical, INC. | $18.56 | 2024 | Summit Doppler |
| Therapeuticsmd, INC. | $17.55 | 2020 | |
| Allergan, INC. | $15.61 | 2019 | |
| Becton, Dickinson and Company | $14.83 | 2022 | |
| Minerva Surgical, INC | $13.63 | 2023 | |
| Olympus America INC. | $12.64 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.53 | 2019 | |
| Dysis Medical, INC. | $12.05 | 2021 | |
| Evofem Biosciences, INC. | $11.91 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Moffat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.